Cargando…
Impact of Patient Age on Clinical Efficacy and Toxicity of Checkpoint Inhibitor Therapy
The addition of immune checkpoint inhibitors (ICIs) to the therapeutic armamentarium for solid malignancies has resulted in unprecedented improvements in patient outcomes in many cancers. The landscape of ICIs continues to evolve with novel approaches such as dual immune checkpoint blockade and comb...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635107/ https://www.ncbi.nlm.nih.gov/pubmed/34868071 http://dx.doi.org/10.3389/fimmu.2021.786046 |